← Back to Analyst Consensus 
GRDN Buy
Guardian Pharmacy Services, Inc.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 23, 2026 | Keybanc | initiate | — → Overweight | — | 53% |
| Sep 21, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Aug 7, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Jun 17, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jun 17, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| May 7, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Apr 27, 2026 | B of A Securities | initiate | — → Buy | — | 53% |
| Apr 13, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Mar 30, 2026 | Jefferies | initiate | — → Buy | — | 52% |
| Mar 12, 2026 | Oppenheimer | maintain | Outperform → Outperform | $38 | 52% |
| Mar 12, 2026 | Truist Securities | maintain | Buy → Buy | $38 | 54% |
| Jan 14, 2026 | Stephens & Co. | maintain | Overweight → Overweight | $36 | 54% |
| Nov 14, 2025 | Truist Securities | maintain | Buy → Buy | $34 | 54% |
| Oct 10, 2025 | Oppenheimer | initiate | — → Outperform | $30 | 52% |
| Sep 26, 2025 | Truist Securities | maintain | Buy → Buy | $30 | 54% |
| May 19, 2025 | Truist Securities | reiterate | Buy → Buy | $28 | 54% |
| Apr 11, 2025 | Truist Securities | maintain | Buy → Buy | $25 | 54% |
| Nov 15, 2024 | Truist Securities | maintain | Buy → Buy | $24 | 54% |
| Oct 22, 2024 | Stephens & Co. | initiate | — → Overweight | $21 | 54% |
| Oct 21, 2024 | Truist Securities | initiate | — → Buy | $22 | 54% |
Price Target Trend
Mar 26, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days